Acquisition by Rouan Sarah Kathryn of 32000 shares of Viking Therapeutics subject to Rule 16b-3

VKTX Stock  USD 51.99  0.60  1.14%   
Slightly above 68% of Viking Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Viking Therapeutics suggests that many traders are alarmed. Viking Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Viking Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Viking Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Viking insider trading alert for grant of stock option right to buy by Rouan Sarah Kathryn, the corporate stakeholder, on 4th of January 2024. This event was filed by Viking Therapeutics Inc with SEC on 2024-01-04. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Viking Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Viking Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Viking Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Viking Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Viking Therapeutics Historical Investor Sentiment

Investor biases related to Viking Therapeutics' public news can be used to forecast risks associated with an investment in Viking. The trend in average sentiment can be used to explain how an investor holding Viking can time the market purely based on public headlines and social activities around Viking Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Viking Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Viking Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Viking Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Viking Therapeutics.

Viking Therapeutics Fundamental Analysis

We analyze Viking Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viking Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viking Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Viking Therapeutics is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Viking Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Viking Therapeutics stock to make a market-neutral strategy. Peer analysis of Viking Therapeutics could also be used in its relative valuation, which is a method of valuing Viking Therapeutics by comparing valuation metrics with similar companies.

Peers

Viking Therapeutics Related Equities

MCRBSeres Therapeutics   15.58   
0%
100.0%
HEPAHepion Pharmaceuticals   3.03   
0%
19.0%
ELEVElevation Oncology   1.67   
0%
10.0%
TERNTerns Pharmaceuticals   1.40   
0%
8.0%
SRPTSarepta Therapeutics   0.37   
0%
2.0%
ABOSAcumen Pharmaceuticals   0.42   
2.0%
0%
PTCTPTC Therapeutics   0.56   
3.0%
0%
MDGLMadrigal Pharmaceuticals   0.65   
4.0%
0%
AXSMAxsome Therapeutics   1.20   
7.0%
0%
DAWNDay One   2.19   
14.0%
0%
OCEAOcean Biomedical   2.78   
17.0%
0%
AKROAkero Therapeutics   2.93   
18.0%
0%
ENVBEnveric Biosciences   3.03   
19.0%
0%
INZYInozyme Pharma   6.05   
38.0%
0%
XFORX4 Pharmaceuticals   8.11   
52.0%
0%
MREOMereo BioPharma   9.14   
58.0%
0%

Additional Tools for Viking Stock Analysis

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.